Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Patent CN108794420B discloses a novel bisoxazoline ligand synthesis from cheap bisphenols, offering significant cost reduction and scalable production for asymmetric catalysis.
Patent CN102516300A discloses efficient phosphine ligands enabling superior enantioselectivity and simplified synthesis for cost-effective pharmaceutical intermediate manufacturing.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.
Patent CN101143862B details novel chiral ionic thiourea catalysts offering high enantioselectivity and recyclability for pharmaceutical intermediate manufacturing.
Patent CN112209947A discloses a mild, high-yield organocatalytic route to chiral indoxazinones with potent anticancer activity, offering significant cost reduction in API manufacturing.
Patent CN106478719B details a novel camphor-based chiral catalyst. Offers high selectivity and metal-free advantages for pharmaceutical intermediates manufacturing cost reduction.
Patent CN102766092A reveals a mild, high-enantioselectivity route for tetrahydroquinolines, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN111925356A discloses stable chiral ligands enabling high-yield nickel-catalyzed lactam synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel biaryl-based ligand enables high-yield palladium-catalyzed asymmetric allylic substitution with exceptional enantioselectivity and simplified synthesis.
Patent CN114409714A reveals a novel Pd-catalyzed method for synthesizing high-purity 1,3-disubstituted planar chiral metallocenes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel two-step synthesis of axial chiral ligands from aryl halides offers cost-effective, high-enantioselectivity solutions for pharmaceutical manufacturing.
Patent CN111777637B details novel indole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand synthesis enabling high-yield asymmetric difunctionalization for cost-effective API manufacturing.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Novel chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Efficient synthesis reduces costs and ensures supply chain reliability for antitumor drug development.